Eph family receptors as therapeutic targets


Anti-angiogenic therapy is currently a commonly accepted and rapidly developing approach in oncology and other pathologies linked to aberrant neovascularization. Discovery and validation of additional molecular targets in angiogenesis is needed due to the limitations of the existing clinical therapeutics inhibiting activity of vascular endothelial growth… (More)
DOI: 10.1134/S106816201203017X


Cite this paper

@article{Zozulya2012EphFR, title={Eph family receptors as therapeutic targets}, author={Sergey A Zozulya and Igor P Udovichenko}, journal={Russian Journal of Bioorganic Chemistry}, year={2012}, volume={38}, pages={231-242} }